Supplemental Figure 5 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer

MLA

Katherine N. Weilbaecher, et al. Supplemental Figure 5 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.22507246.v1.

APA

Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, Gérald Tuffin, Barbara Romagnoli, Foluso O. Ademuyiwa, Timothy Pluard, Kathryn E. Luker, Chidananda Mudalagiriyappa, Garry J. Douglas, Alison K. Esser, Sarah R. Amend, Xinming Su, Francesca Fontana, Michelle A. Hurchla, & Jingyu Xiang. (2023). Supplemental Figure 5 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer. https://doi.org/10.1158/1535-7163.22507246.v1

Chicago

Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, et al. 2023. “Supplemental Figure 5 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer,” April. doi:10.1158/1535-7163.22507246.v1.